Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma
Clinical trial NCT02914405 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02914405
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2025-06-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.